WuXi Biologics (Cayman) Inc (WXIBF)
1.63
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
WuXi Biologics Price to Book Value: 1.192 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 1.192 |
May 02, 2024 | 1.192 |
May 01, 2024 | 1.192 |
April 30, 2024 | 1.229 |
April 29, 2024 | 1.229 |
April 26, 2024 | 1.229 |
April 25, 2024 | 1.204 |
April 24, 2024 | 1.204 |
April 23, 2024 | 1.240 |
April 22, 2024 | 1.241 |
April 19, 2024 | 1.241 |
April 18, 2024 | 1.242 |
April 17, 2024 | 1.245 |
April 16, 2024 | 1.245 |
April 15, 2024 | 1.247 |
April 12, 2024 | 1.326 |
April 11, 2024 | 1.326 |
April 10, 2024 | 1.326 |
April 09, 2024 | 1.224 |
April 08, 2024 | 1.224 |
April 05, 2024 | 1.224 |
April 04, 2024 | 1.224 |
April 03, 2024 | 1.224 |
April 02, 2024 | 1.224 |
April 01, 2024 | 1.357 |
Date | Value |
---|---|
March 28, 2024 | 1.393 |
March 27, 2024 | 1.273 |
March 26, 2024 | 1.273 |
March 25, 2024 | 1.321 |
March 22, 2024 | 1.321 |
March 21, 2024 | 1.358 |
March 20, 2024 | 1.372 |
March 19, 2024 | 1.791 |
March 18, 2024 | 1.791 |
March 15, 2024 | 1.791 |
March 14, 2024 | 1.791 |
March 13, 2024 | 1.791 |
March 12, 2024 | 1.747 |
March 11, 2024 | 1.651 |
March 08, 2024 | 1.651 |
March 07, 2024 | 1.651 |
March 06, 2024 | 1.651 |
March 05, 2024 | 1.886 |
March 04, 2024 | 1.886 |
March 01, 2024 | 1.769 |
February 29, 2024 | 1.769 |
February 28, 2024 | 1.769 |
February 27, 2024 | 1.769 |
February 26, 2024 | 1.879 |
February 23, 2024 | 1.695 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.192
Minimum
May 01 2024
72.72
Maximum
Nov 16 2020
10.32
Average
9.158
Median
Dec 21 2021
Price to Book Value Benchmarks
Wuxi AppTec Co Ltd | 1.790 |
Zai Lab Ltd | 2.025 |
I-MAB | 0.5873 |
Gracell Biotechnologies Inc (DELISTED) | -- |
Price to Book Value Related Metrics
PE Ratio | 14.96 |
PS Ratio | 2.956 |
Price to Free Cash Flow | 115.31 |
Price | 1.63 |
Earnings Yield | 6.68% |
Market Cap | 6.785B |
Operating PE Ratio | 11.29 |
Normalized PE Ratio | 14.29 |